Literature DB >> 7751640

Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Local and regional participation of IFN-gamma, IL-10, and TNF.

S W Chensue1, K S Warmington, J H Ruth, P Lincoln, S L Kunkel.   

Abstract

Pulmonary granulomas (GR) with type 1 or type 2 cytokine involvement were induced in presensitized CBA mice by embolization of beads coupled to purified protein derivative (PPD) of Mycobacterium tuberculosis or soluble Ags derived from Schistosoma mansoni eggs (SEA). Using neutralizing Abs against IFN-gamma, IL-10, and TNF-alpha/beta, we examined effects on GR size, GR macrophage function, and regional lymph node (LN) responses. Profoundly different effects were observed in the two models. Anti-IFN decreased PPD-GR size by 20%, but augmented SEA GR by nearly 50%. Anti-TNF abrogated PPD-GR area by 40% and SEA GR by 15% suggesting that TNF contributed more to the former. Anti-IL-10 did not affect GR sizes. Analysis of TNF indicated that IFN was required for maximum production by both PPD GR and SEA GR macrophages. Interestingly, TNF tempered its own expression by SEA GR macrophages. In LN, PPD GR and SEA GR formation was associated with T cell-dependent type 1 (IFN and IL-2) and type 2 (IL-10 and IL-4) cytokine profiles, respectively. In PPD LN, anti-IFN decreased IFN and IL-2 production by 50%. In contrast, anti-IL-10 increased IFN and IL-2 production by two- to fourfold, indicating that IFN and IL-10 had opposing effects on the type 1 response. In SEA LN, anti-IFN decreased IFN production but augmented IL-4 and IL-10 production by 50 and 90%, respectively, supporting the notion that IFN constrains Th2 responses. Conversely, IL-10 promoted the Th2 response. Surprisingly, anti-TNF reduced IL-4 and IL-10 in SEA LN but did not affect PPD LN, suggesting that TNF-alpha or -beta supports Th2 differentiation in LN during the secondary response to schistosomal Ags.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751640

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Impaired lung dendritic cell activation in CCR2 knockout mice.

Authors:  Bo-Chin Chiu; Christine M Freeman; Valerie R Stolberg; Jerry S Hu; Kyriaki Zeibecoglou; Bao Lu; Craig Gerard; Israel F Charo; Sergio A Lira; Stephen W Chensue
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

2.  A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Authors:  Kerry J Welsh; April N Abbott; Shen-An Hwang; Jessica Indrigo; Lisa Y Armitige; Michael R Blackburn; Robert L Hunter; Jeffrey K Actor
Journal:  Microbiology (Reading)       Date:  2008-06       Impact factor: 2.777

3.  AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formation.

Authors:  Jerry S Hu; Christine M Freeman; Valerie R Stolberg; Bo Chin Chiu; Gary J Bridger; Simon P Fricker; Nicholas W Lukacs; Stephen W Chensue
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

4.  Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide.

Authors:  Carmen M Swaisgood; Kyra Oswald-Richter; Stephen D Moeller; Jennifer M Klemenc; Lisa M Ruple; Carol F Farver; John M Drake; Daniel A Culver; Wonder P Drake
Journal:  Am J Respir Cell Mol Biol       Date:  2010-03-26       Impact factor: 6.914

Review 5.  Tumour necrosis factor and Crohn's disease.

Authors:  S J Van Deventer
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

6.  Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge.

Authors:  Margaret R Gyetko; Sudha Sud; Stephen W Chensue
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4.

Authors:  Toshihiro Ito; Matthew Schaller; Cory M Hogaboam; Theodore J Standiford; Matyas Sandor; Nicholas W Lukacs; Stephen W Chensue; Steven L Kunkel
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

8.  Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma.

Authors:  Mohammad Fallahi-Sichani; Matthew A Schaller; Denise E Kirschner; Steven L Kunkel; Jennifer J Linderman
Journal:  PLoS Comput Biol       Date:  2010-05-06       Impact factor: 4.475

9.  Eosinophil recruitment in type-2 hypersensitivity pulmonary granulomas: source and contribution of monocyte chemotactic protein-3 (CCL7).

Authors:  Xiao-Zhou Shang; Bo-Chin Chiu; Valerie Stolberg; Nicholas W Lukacs; Steven L Kunkel; Hedwig S Murphy; Stephen W Chensue
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

10.  Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis.

Authors:  José Luis Callejas-Rubio; Lourdes López-Pérez; Norberto Ortego-Centeno
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.